Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR versus sertraline adjunctive therapy for acute bipolar depression
2008-002649-22Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of quetiapine and sertraline in bipolar disorder (BD) (2 arms), sponsored by AstraZeneca. Started Nov 2008; status: completed.
02
Drugs
quetiapinesertraline
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2008-002649-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002649-22.